Continuous readout versus titer-based assays of influenza vaccine trials: sensitivity, specificity, and false discovery rates

DOI10.1155/2019/9287120MaRDI QIDQ2003708zbMATH OpenOpenAlexDBLPWikidataFDO

Authors Dongmei Li, Jiong Wang, Jessica Garigen, John J. Treanor, Martin S. Zand

Publication date 9 July 2019

Published in Computational \& Mathematical Methods in Medicine (Search for Journal in Brave)

Copyright license Creative Commons Attribution 4.0 International

Full work available at URL https://doi.org/10.1155/2019/9287120

zbMATH Keywords

false discovery rateshemagglutinin inhibition assayinfluenza vaccine trialsmicroneutralization assay

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical epidemiology (92C60)

Recommendations

• Comparisons of titer estimation methods for multiplexed pneumococcal opsonophagocytic Killing assay
• A Mixed Model for Repeated Dilution Assays
• The Effect of Serial Dilution Error on Calibration Inference in Immunoassay
• Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance
• Estimating Numbers of Infectious Units from Serial Dilution Assays

Cites work

• Newton-Raphson and EM Algorithms for Linear Mixed-Effects Models for Repeated-Measures Data
• Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression

Cited in

(1)

• Comparisons of titer estimation methods for multiplexed pneumococcal opsonophagocytic Killing assay

This page was built for publication: Continuous readout versus titer-based assays of influenza vaccine trials: sensitivity, specificity, and false discovery rates

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2003708)